PKI Share Price

Open 66.36 Change Price %
High 66.41 1 Day -0.30 -0.45
Low 65.57 1 Week -3.73 -5.37
Close 65.79 1 Month -2.49 -3.65
Volume 809990 1 Year 10.20 18.35
52 Week High 70.16
52 Week Low 45.35
PKI Important Levels
Resistance 2 66.57
Resistance 1 66.25
Pivot 65.92
Support 1 65.33
Support 2 65.01
NYSE USA Most Active Stocks
RAI 65.40 -2.23%
RAI 65.40 -2.23%
AMD 14.12 -4.34%
AMD 14.12 -4.34%
AMD 14.12 -4.34%
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
GNC 10.95 16.86%
GNC 10.95 16.86%
GNC 10.95 16.86%
FNP 35.24 12.02%
FNP 35.24 12.02%
TK 9.55 11.44%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

PerkinElmer, Inc. (NYSE: PKI)

PKI Technical Analysis 1.5
As on 27th Jul 2017 PKI Share Price closed @ 65.79 and we RECOMMEND Buy for LONG-TERM with Stoploss of 57.00 & Sell for SHORT-TERM with Stoploss of 65.83 we also expect STOCK to react on Following IMPORTANT LEVELS.
PKI Target for July
1st Target up-side 71.39
2nd Target up-side 73.67
3rd Target up-side 75.95
1st Target down-side 64.89
2nd Target down-side 62.61
3rd Target down-side 60.33
PKI Other Details
Segment EQ
Market Capital 3584113920.00
Sector Healthcare
Industry Medical Laboratories & Research
Offical website http://www.perkinelmer.com
PKI Address
PKI
940 Winter Street
Waltham, MA 02451
United States
Phone: 781-663-6900
PKI Latest News
Interactive Technical Analysis Chart PerkinElmer, Inc. ( PKI NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on PerkinElmer, Inc.
PKI Business Profile
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, research, environmental, industrial, and laboratory services markets worldwide. The company operates through two segments, Human Health and Environmental Health. The Human Health segment develops diagnostics, tools, and applications to help detect diseases earlier, and to accelerates the discovery and development of critical new therapies. This segment provides early detection for genetic disorders from pre-conception to early childhood, as well as offers digital x-ray flat panel detectors and infectious disease testing for the diagnostics market; and a suite of solutions, such as reagents, liquid handling, and detection and imaging technologies that enable researchers to improve the drug discovery process. Its research portfolio includes instrumentation for automation and detection solutions, in vitro and in vivo imaging and analysis hardware and software, and a portfolio of consumable products, including drug discovery and research reagents. The Environmental Health segment provides services and solutions to facilitate the creation of safer food and consumer products, secure surroundings, and efficient energy resources. This segment offers analytical technologies, solutions, and services that enable its customers to understand the health aspects of environment, including air, water, soil, and food; analytical instrumentation for the industrial market that comprise the chemical, petrochemical, lubricant, electronics, semiconductor, and quality assurance industries; and laboratory services. The company markets its products and services under various brands directly through its own sales force. Its customers include pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1931 and is headquartered in Waltham, Massachusetts.